| Literature DB >> 9507713 |
Abstract
A woman with atopy experienced anaphylaxis after taking, among other dietary supplements, a commercial extract of echinacea. Hypersensitivity was confirmed by skinprick and RAST testing. Regular ingestion of echinacea by up to 5% of surveyed patients with atopy, combined with detection of echinacea-binding IgE in atopic subjects (19% by skin testing; 20% with moderate to strong reactivity by RAST testing), raises the possibility of severe allergic reactions, even with first-time use, due to cross-reactivity with other structurally similar allergens. Patients with atopy should be cautioned about the risk of developing life-threatening reactions to complementary medicines, including echinacea.Entities:
Mesh:
Substances:
Year: 1998 PMID: 9507713 DOI: 10.5694/j.1326-5377.1998.tb126773.x
Source DB: PubMed Journal: Med J Aust ISSN: 0025-729X Impact factor: 7.738